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Abstract: Successful revascularisation of chronic total occlusions (CTOs) remains one of the greatest challenges in the 
era of contemporary percutaneous coronary intervention (PCI). Such lesions are encountered with increasing frequency in 
current clinical practice. A predictable increase in the future burden of CTO management can be anticipated given the 
ageing population, increased rates of renal failure, graft failure and diabetes mellitus. Given recent advances and devel-
opments in CTO PCI management, successful recanalisation can be anticipated in the majority of procedures undertaken 
at high-volume centres when performed by expert operators.  
Despite advances in device technology, the management of resistant, calcific lesions remains one of the greatest chal-
lenges in successful CTO intervention. Established techniques to modify calcific lesions include the use of high-pressure 
non-compliant balloon dilation, cutting-balloons, anchor balloons and high speed rotational atherectomy (HSRA). Novel 
approaches have proven to be safe and technically feasible where standard approaches have failed. A step-wise progres-
sion of strategies is demonstrated, from well-recognised techniques to techniques that should only be considered when 
standard manoeuvres have proven unsuccessful. These methods will be described in the setting of clinical examples and 
include use of very high-pressure non-compliant balloon dilation, intentional balloon rupture with vessel dissection or bal-
loon assisted micro-dissection (BAM), excimer coronary laser atherectomy (ECLA) and use of HSRA in various ‘off-
label’ settings. 
Keywords: Chronic total occlusions, dissection re-entry techniques, excimer coronary laser atherectomy, high speed rotational 
atherectomy, novel revascularisation techniques. 
INTRODUCTION 
 In the contemporary era of interventional cardiology, 
chronic total occlusions (CTOs) are encountered with in-
creasing frequency. Data from the Canadian Multicentre 
Chronic Total Occlusions Registry cited a CTO prevalence 
rate of 18.4% in all patients undergoing non-urgent coronary 
angiography [1]. Given the ageing population, increasing 
rates of renal failure and diabetes mellitus, one can anticipate 
a further increase in the burden of chronic occlusion man-
agement in the future. In addition, re-interventions are fre-
quently encountered in the post-coronary artery bypass graft 
(CABG) group of patients, where the incidence of CTOs is > 
50% [2]. Documented benefits of successful CTO interven-
tion include improved left ventricular function, reduced an-
gina frequency and enhanced exercise capacity [3]. The im-
portance of complete revascularisation (CR) in multi-vessel 
coronary disease has been highlighted in several studies. In 
the New York State PCI database, CR was demonstrated to 
be a positive prognostic factor [4]. Conversely, incomplete 
revascularisation (IR) after PCI has been associated with 
adverse clinical outcomes [5]. 
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 The greatest obstacles to successful recanalisation are 
related to vessel calcification and collateral channel tortuos-
ity. However, despite the challenges associated with CTO 
PCI, recanalisation rates of > 85% can now be expected at 
experienced high-volume centres [6]. In the hands of appro-
priately experienced operators, there are few angiographic 
exclusions to contemporary CTO PCI. This was highlighted 
in the FAST-CTO trial, where novel hybrid revascularisation 
approaches were studied in 147 patients with a previously 
failed CTO PCI attempt. With an emphasis on the use of 
dissection / re-entry techniques, successful recanalisation 
rates were 87% in a sub-group of 75 cases. The 30-day major 
adverse clinical event (MACE) rate was acceptable at 4.8% 
[7].  
 To facilitate successful CTO recanalisation, a strategic 
approach combining understanding of lesion characteris-
tics, coronary anatomy and adjunctive techniques should be 
used. To enhance procedural outcomes and CTO recanali-
sation rates, the operator should be familiar in the use and 
handling of a range of techniques and devices. The success-
ful revascularisation of resistant coronary lesions is de-
pendent on methods that enhance lesion crossing and meth-
ods that enhance lesion modification (Tables 1 & 2). De-
tails of these approaches will be discussed further in the 
case examples.  
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Table 1. Methods to facilitate lesion crossing. 
• Large active support catheters 
• Anchor balloon techniques 
• Extension catheters 
• Terumo Heartrail II 
• GuideLiner 




• Advanced wiring strategies 
• Antegrade / retrograde wiring 
• CART / Reverse CART 
 
Table 2. Methods to facilitate lesion modification. 
• Very high-pressure balloon post-dilation 
• Intentional balloon rupture / balloon assisted micro-dissection 
(BAM) 
• Excimer coronary laser atherectomy (ECLA) 
• Combined ECLA with high-speed rotational atherectomy 
(HSRA) 
• High-speed rotational atherectomy (HSRA) alone 
 
WIRE TECHNIQUES AND STRATEGIES 
 In addition to strategies to facilitate lesion crossing and 
lesion modification, guidewire selection greatly influences 
the ability of an operator to successfully cross a lesion and 
wire the distal vessel true lumen. A variety of guidewires 
and supplementary manoeuvres specific to lesion subsets are 
available. Detailed discussions of advanced guidewire tech-
nology are beyond the scope of this text, but have led to in-
creased rates of successful lesion crossing. It is generally 
recognised that simple, focal lesions can be effectively and 
safely wired by skilled operators.  
 In the J-CTO trial, utilisation of advanced guidewires 
facilitated successful lesion crossing in 88.6% of CTO cases 
[8]. All CTO operators should be familiar with the handling 
of a range of guidewires (including stiff, tapered CTO-
specific wires), as appropriate selection may influence revas-
cularisation success rates. It should be remembered that 
CTO-specific guidewires are more prone to enter sub-intimal 
channels, and may increase the risk of perforation. In one 
study, unintentional sub-intimal wire tracking occurred in 
45% of CTO lesions as documented by intravascular ultra-
sound (IVUS) assessment [9].  
 More recently, advances in antegrade or retrograde wir-
ing with dissection and re-entry techniques have afforded the 
opportunity of high procedural success rates with limited 
complications. Such techniques are facilitated by novel 
equipment including the CrossBoss™ and Stingray™ (Bos-
ton Scientific, Natick, MA) devices. Further details of these 
devices plus a discussion of retrograde wiring techniques 
will be considered in companion articles in this issue of the 
journal. In cases where crossing the proximal cap is found to 
be extremely challenging or impossible with standard tech-
niques, deliberate bypassing of the cap by entering the sub-
intimal space and performing antegrade or retrograde dissec-
tion, may facilitate a successful outcome. This is known as 
controlled antegrade and retrograde sub-intimal tracking 
(CART) [10]. These methods are described in detail in com-
panion articles in this publication. Nevertheless, this option 
can be considered under appropriate circumstances.  
METHODS TO FACILITATE LESION CROSSING 
a) Anchor Balloon Support Techniques 
 Anchor balloon support techniques remain a robust 
method to facilitate crossing of at least moderately resistant 
coronary lesions. Typically, proximal anchor balloon infla-
tion in a side-branch enhances guide catheter stability and 
increases support prior to crossing the occlusion with a 
guidewire, micro-catheter or balloon [11]. Care should be 
taken with proximal anchor balloons, and over-sizing of the 
balloon diameter should be avoided to prevent side-branch 
disruption or perforation. Arrhythmias or significant ischae-
mia can be precipitated, although in our experience these 
events are very rare.  In addition to placing an anchor bal-
loon in a side-branch, it is also possible to trap a micro-
catheter (usually a Corsair; Asahi Intecc, Japan) within the 
main vessel to facilitate extreme support for guidewire ad-
vancement through the occluded segment. When 8F guide 
catheters are used it is possible to use an anchor balloon in 
the side-branch as well as the main vessel with a Corsair, 
thus providing extreme support. If a lesion is successfully 
crossed, balloon inflation distal to, or even within the target 
lesion can also facilitate delivery of secondary equipment 
[12]. This distal balloon anchoring technique has also been 
described and used as an adjunct for the delivery of secon-
dary equipment.  
b) Extension Catheters 
 The introduction of extension catheters increased the 
success rate of lesion crossing by improving guide catheter 
support. The initial, low-profile Terumo Heartrail II (Te-
rumo, Japan) catheter had relatively limited clinical utility 
due to its smaller lumen capacity, greater catheter length and 
subsequent requirement for long wire exchanges. More re-
cently, the GuideLiner™ catheter (Vascular Solutions, Ma-
ple Grove, MN) was developed as a monorail or rapid-
exchange mother and daughter system. The GuideLiner™ 
consists of a short guide-catheter extension connected to an 
introducer rod. The major advantage of the device is that is 
can be safely engaged very deeply in the distal vessel over an 
anchor balloon to allow stent delivery. In one of the first 
studies assessing its clinical utility, the device success rate 
was 93% in a series of 70 PCI cases. Of note, the greatest 
benefit was found in those cases with tortuous anatomy and 
complex, calcified lesions [13]. For this reason, it has be-
come an established treatment modality in contemporary 
PCI. 
Challenges in the Management of Calcific Coronary Lesions Current Cardiology Reviews, 2014, Vol. 10, No. 2     147 
c) Micro-catheters 
 Micro-catheters were specifically developed to enhance 
lesion crossing and can substantially enhance the support 
offered to the guidewire when they are engaged within the 
CTO. A range of micro-catheters are available including the 
Quickcross (Spectranetics Corp, Colorado Springs, CO), 
Finecross (Terumo, Japan), NHancer (Interventional Medical 
Device Solutions, Netherlands), Corsair and Tornus (Asahi 
Intecc, Japan) devices. The Tornus and Corsair systems are 
manufactured from metallic alloys allowing the operator to 
cross difficult lesions and/or dilate collateral channels whilst 
being kink and compression resistant. Both of these micro-
catheters can be used in conjunction with anchor balloon 
support to further enhance lesion crossing. 
Tornus (Asahi Intecc, Japan) 
 The Tornus was introduced in 2004 [14] to facilitate le-
sion crossing in those cases where the guidewire had only 
partially penetrated the lesion cap [12]. The device consists 
of a stainless steel, wire braided catheter (either 2.1F or 
2.6F). It has a tapered steel tip to increase penetration and a 
silicone coating to increase lubricity. After the Tornus has 
crossed a lesion, this facilitates successful passage of low-
profile balloons whilst minimizing the risk of vessel dissec-
tion or disruption. It can also be used to increase support to 
facilitate guidewire advancement [15]. The clinical utility of 
the device has been demonstrated in several studies, with 
successful revascularisation following its use in 91% cases 
of a cohort of 44 PCI patients [16], and 71.4% of a cohort of 
56 severely calcified CTO lesions [17].  
Corsair (Asahi Intecc, Japan) 
 The development of the Corsair micro-catheter has com-
plimented the use of the Tornus, as it has additional benefits 
as a collateral channel dilator. The Corsair is a braided mi-
cro-catheter consisting of 10 interwoven wires which form a 
polymer-covered metallic tube. The device has a kink-
resistant, tapered tip to ease access to complex channels. The 
device improves wire support and wire manipulation. The 
Corsair also has the added advantage of allowing contrast 
injection through the catheter to delineate collateral chan-
nels. The Corsair will also frequently cross resistant lesions 
with or without balloon anchor support. 
METHODS TO FACILITATE LESION MODIFICA-
TION 
 Calcified CTO segments present specific obstacles to 
successful revascularisation. The nature of the fibro-
calcific plaque reduces vessel distensibility, making it 
resistant to aggressive balloon dilation. This increases the 
risk of stent under-expansion [18], late in-stent restenosis 
and adverse clinical events. Once the lesion has been suc-
cessfully crossed, further challenges related to lesion 
modification can arise. A spectrum of techniques with 
escalating complexity can be considered when faced with 
challenging lesion modification (Table 2). These strate-
gies will be further discussed in the setting of case-based 
examples. It must be highlighted that these measures 
should be considered ‘last resort’ measures where stan-
dard techniques have proved unsuccessful. The descrip-
tions of device use in the cases of balloon assisted micro-
dissection (BAM), excimer laser coronary atherectomy 
(ELCA) and high speed rotational atherectomy (HSRA) in 
these CTO cases are all ‘off-license’ settings and are con-
traindicated in “Instructions for Use” documents. There-
fore, such techniques should be performed by experienced 
CTO operators familiar with these advanced techniques, 
specific device use, potential complications and the man-
agement of complications should they arise. 
a) Very High-pressure Non-compliant Balloon Dilation 
 Very-high pressure balloon dilation is the most fre-
quently employed strategy to manage resistant lesions. Non-
compliant (NC) balloons facilitate lesion modification by 
delivering high intra-luminal pressures. In addition to stan-
dard non-compliant balloons, ultra non-compliant balloons 
such as the Schwager OPN balloon (SIS Medical, Switzer-
land), have been developed to deliver high post-dilation 
pressures of >40 atm. Operators must remember that there is 
an increased risk of vessel perforation when utilising very 
high pressure post-dilation strategies. 
 Case example: A 41-year old ex-smoker with previous 
left anterior descending (LAD) artery stenting presented with 
a CTO of the proximal right coronary artery (RCA). There 
was no proximal or distal cap ambiguity, the occlusion was 
long (50mm), and the septal collaterals to the distal RCA 
were usable. The chosen interventional strategy was a pri-
mary retrograde approach. A Sion wire (Asahi Intecc, Japan) 
was advanced retrogradely to the distal RCA via the 2nd sep-
tal branch. The Sion wire was exchanged for a Pilot 200 wire 
(Abbott Vascular, Santa Clara, CA) facilitating advancement 
of a Corsair micro-catheter to the mid-RCA. The antegrade 
channel was accessed with a Progress 200T wire (Abbott 
Vascular, Santa Clara, CA) with anchor balloon support. 
Sequential antegrade balloon dilations were performed to 
connect the sub-intimal spaces (reverse CART). A heavily 
calcified proximal RCA lesion persisted, and was modified 
with repeated high pressure inflations at 30 atm using a 3.0 
Quantum NC balloon (Boston Scientific, Natick, MA). The 
retrograde Pilot 200 wire was advanced into the RCA guide, 
exchanged for an RG3 (Asahi Intecc, Japan), and external-
ised. The vessel was reconstructed with Promus Element 
stents (Boston Scientific, Natick, MA) and post-dilated with 
non-compliant balloons (3.0 in main lumen; 4.0 at the 
ostium). In this case, very high pressure inflation with a non-
compliant balloon successfully modified the resistant lesion 
(Fig. 1). 
b) Intentional Balloon Rupture / Balloon Assisted Micro-
dissection (BAM) 
 The primary intention with BAM is to cause intentional 
and controlled vessel dissection, thus facilitating delivery of 
secondary equipment beyond the calcific lesion. This is an 
‘off license’ technique and should be regarded as a ‘last re-
sort’ measure where other strategies have failed. In the ma-
jority of cases, a very small diameter balloon is used (1.2 or 
1.5mm) although larger balloons can be required at very re-
sistant proximal caps. Three case examples highlighting the 
successful use of BAM will be further described. 
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Case 1 
 A 57-year old hypertensive, diabetic male presented with 
a heavily calcified CTO of the proximal RCA having under-
gone previous PCI to the left circumflex (LCx). The chosen 
strategy was a primary retrograde approach with a 3D guide 
in the RCA and VL3.5 guide in the LCA. The heavily calci-
fied proximal CTO cap was eventually penetrated with a 
ProVia 15g wire (Medtronic, Minneapolis, MN). It was not 
possible to advance any secondary equipment into the CTO. 
There were no proximal branches available to allow an an-
chor balloon to be sited. The patent proximal vessel was also 
too short to place an anchor balloon in this segment (Fig. 2). 
In this case, a series of balloon were brought in as close to 
the proximal cap of the lesion as possible and ruptured at 
high pressure (1.2, 1.5, 2.0 and 2.5mm balloons). Eventually, 
micro-dissection was created within the CTO segment and it 
was possible to pass a Corsair and knuckle wire into the ar-
chitecture of the vessel, eventually facilitating a successful 
reverse CART procedure. 
Case 2 
 A 68-year old male with a previous CABG presented 
with a CTO of the RCA and an occluded saphenous vein 
graft (SVG) to this territory. There was no proximal cap am-
biguity, the CTO length was < 20mm and the distal vessel 
was of good calibre. The chosen strategy was an antegrade 
approach. A Progress 200 wire was passed to the distal true 
lumen but secondary equipment could not be advanced be-
yond the distal portion of the occlusion segment despite the 
use of multiple semi-compliant balloons, a Finecross micro-
catheter (Terumo, Japan), anchor balloons, a 2.6F Tornus 
(Asahi Intecc, Japan) micro-catheter and a Tornus plus an-
chor balloon. It was not possible to deliver any of the micro-
catheters far enough into the lesion to facilitate passage of a 
rota floppy wire. Thus, BAM was performed at the point of 
obstruction using a 1.2 Minitrek balloon (Abbott Vascular, 
Santa Clara, CA) resulting in extensive intentional vessel 
dissection along a sub-intimal channel extending as far as the 
heart border. This facilitated successful balloon passage to 
the distal true lumen. Further pre-dilation allowed vessel 
reconstruction with sequential Nobori DES (Terumo, Japan) 
(Fig. 3). 
Case 3 
 A 57-year old male with previous PCI to the LAD pre-
sented with refractory angina symptoms. There was a known 
CTO of the RCA with collateralisation from the distal cir-
cumflex artery. The chosen interventional strategy was an 
antegrade approach with an 8F AL 0.75 Guide. An antegrade 
Pilot 200 wire was used to enter the proximal lesion but 
semi-compliant balloons, a Corsair and a CrossBoss™ cathe-
ter (Boston Scientific, Natick, MA) would not cross the 
 
Fig. (1). Panel A: There is a proximal CTO of the RCA with multiple septal collaterals from the LAD (arrow). Panel B: An antegrade Pro-
gress wire has successfully crossed the proximal CTO cap. A retrograde Pilot 200 wire has been advanced through the septal collaterals of 
the LAD to the chronic occlusion with assistance of a Corsair micro-catheter. Sequential antegrade balloon dilations have been performed to 
connect the sub-intimal channel (arrow). Panel C: A heavily calcified proximal RCA lesion persists, despite pre-dilation. This resistant area 
is further modified with a high-pressure non-compliant balloon at 30atm. Panel D: The vessel is then reconstructed using overlapping Pro-
mus Element DES (2.5/18, 3/12, 3/38). 
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Fig. (2). Panel A: There is a proximal occlusion of the right coronary artery. There are no branches to allow an anchor balloon to be sited. A 
ProVia 15g wire (Medtronic, Minneapolis, MN) has penetrated a short distance into the occlusion segment (arrow), although a Corsair will 
not pass beyond the cap. Panel B: A 2.5mm balloon is brought as close to the proximal cap and inflated. Panel C: The balloon is deliberately 
ruptured to created micro-dissection within the CTO segment. Panel D: This manoeuvre allows a knuckle wire and Corsair catheter to be 
advanced beyond the proximal cap into the CTO segment to facilitate a reverse CART. 
 
 
Fig. (3). Panel A: There is a heavily calcified CTO of the proximal RCA, and use of a GuideLiner™ extension catheter is required to facili-
tate lesion crossing with a guidewire. Panel B: The lesion is successful crossed and a guidewire is advanced to the distal vessel. However, a 
range of balloons, a Finecross, and a Tornus micro-catheter (with anchor an anchor balloon), cannot be delivered to the distal vessel. Panel C: 
To allow delivery of secondary equipment to the vessel, intentional balloon rupture with controlled micro-dissection is performed (arrow). 
Panel D: This enables balloon and stent delivery to the distal vessel to aid successful revascularisation. 
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lesion. Thus, BAM was performed and this led to contrast 
passage directly into the distal true lumen. The distal vessel 
was then wired, pre-dilated and reconstructed with overlap-
ping Promus Element stents that were post-dilated with a 
4.0mm NC balloon (Fig. 4).  
 This demonstrates BAM plus contrast-guided re-entry as 
an option to facilitate successful recanalisation from within a 
CTO segment. A contrast-guided Sub-intimal Tracking and 
Re-entry (STAR) technique was developed as a modification 
of the original STAR method [19]. The STAR technique was 
first described by Colombo in 2005, and consists of creating 
a blunt sub-intimal dissection plane with a J-looped 0.014’ 
hydrophilic wire and a supporting OTW balloon, with sub-
sequent wire manipulation to re-enter the vessel true lumen 
[20]. The clinical use of the technique was limited by less 
predictable results and the lack of angiographic guidance 
when creating a sub-intimal dissection plane. In the contrast-
guided STAR technique, a CTO guidewire and an over-the-
wire (OTW) balloon are used to penetrate the proximal cap 
of the lesion. The distal tip of the balloon is then inserted 
into the occlusive segment and the wire is withdrawn. Ap-
proximately 1–2mls of contrast are injected into the occlu-
sion and confirmation of contrast within the vessel architec-
ture or into the distal lumen facilitates further wire progres-
sion. Higher procedural success rates (82.3%) were seen 
with the contrast-guided STAR technique in a case series of 
68 patients, with fewer perforations in comparison to the 
original STAR technique (4.4% vs. 9.7%) [19]. In this case, 
the BAM manoeuvre represents a higher pressure extension 
of the previously described contrast based STAR procedure. 
Whilst this is somewhat uncontrolled and may be unpredict-
able, BAM may lead to an acceptable outcome when no 
other options are available. 
Excimer laser coronary atherectomy (ELCA) and/or HSRA 
 ELCA (Spectranetics Corp, Colorado Springs, CO) is a 
useful adjunct in the management of severe fibro-calcific 
lesions following successful lesion crossing with a guidewire 
[21]. The ELCA catheters can be delivered with a standard 
0.014” guidewire and are available in 0.9 mm, 1.4 mm, 1.7 
mm, and 2.0 mm sizes. The 1.7 mm and 2.0 mm catheters 
are compatible with 7 F and 8 F guide catheters respectively 
while the 0.9 mm and 1.4mm can be used with 6 F guide 
catheters [22]. The 0.9 mm ELCA catheter is routinely used 
in CTO cases. 
 The ELCA delivers rapid ultraviolet B (UVB) light 
pulses to a coronary lesion. The light in the UVB region has 
a wavelength of 308 nm, with a shallow absorption depth of 
50 microns. This shallow absorption depth limits medial and 
adventitial tissue damage in standard PCI. ELCA can emit 
high energy pulses lasting only a fraction of a second. The 
number of pulses emitted during a one second period is 
known as the ‘pulse repetition rate’. The duration of each 
pulse is termed a ‘pulse width’, which can be modified ac-
cording to the nature of the treated lesion. Tissue breakdown 
via photo-ablation occurs in three steps. Firstly, rapid UV 
 
Fig. (4). Panel A: There is a proximal CTO of the RCA, which is collateralised from the distal circumflex artery. Panel B: An antegrade Pilot 
200 wire crosses the proximal lesion cap into the lesion. However, due to the resistant nature of the lesion, a range of semi-compliant bal-
loons, a Corsair, and a CrossBoss™ catheter cannot be advanced any further. Panel C: Balloon assisted micro-dissection (BAM) is then per-
formed by inflating a semi-compliant balloon at high-pressure in order to cause controlled dissection. This leads to immediate contrast pas-
sage into the distal true lumen. Panel D: As the distal true lumen has been re-entered with contrast, the vessel is re-wired, re-dilated and re-
constructed with overlapping DES.  
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light absorption occurs resulting in severing of carbon-
carbon bonds, with subsequent dissipation of energy. This 
energy dissipation leads to evaporation of intracellular water 
to produce a steam bubble that advances ahead of the laser 
catheter. Tissue breakdown occurs due to rapid expansion 
and contraction of these steam bubbles. The threshold energy 
required for the penetration of UV light into the surrounding 
tissue and the subsequent creation of a steam bubble is called 
‘fluence’ (range: 30-80 mJ/mm2). High pulse energy delivery 
is more efficacious in managing calcified lesions. The resul-
tant debris particles are <10 microns in diameter with mini-
mal risk of distal embolization.  
 Recently, data from a 4-year retrospective analysis of 
ELCA cases performed following balloon failure, has dem-
onstrated ELCA to be an effective and safe adjunctive treat-
ment. ELCA was used in 62% cases of balloon failure, with 
an overall procedural success rate of 91% [22]. There are 
cautionary notes to be made when considering ECLA as an 
adjunctive strategy. Its use should be limited only to cases of 
“true-lumen to true-lumen” antegrade wiring when the op-
erator is certain the guidewire is intra-luminal. ELCA should 
not be used in cases where there is concern that the wire has 
taken a deep sub-intimal route. ELCA catheters are relatively 
indiscriminate in performing tissue ablation and will essen-
tially ‘modify’ any tissue in their field of delivery (calcific / 
adventitia or otherwise). Thus, there is a greater risk of per-
foration compared to HSRA. The role of ELCA in the pres-
ence of very heavy lesion calcification is also more limited. 
If the lesion remains unexpandable, combined use of ELCA 
and HSRA can be performed in the hands of experienced 
operators familiar with the technology. 
c) ELCA 
 Case example: A 77-year old woman with angina, pre-
served left ventricular (LV) systolic function presented with 
a known CTO of the left circumflex. Despite successful 
crossing of the lesion with a guidewire, micro-catheters and 
a range of balloons could not be advanced distally. There-
fore, a 0.9 mm, X-80 ELCA catheter was used to deliver 
laser at a fluence of 60 mJ/mm2 (repetition rate 40 Hertz; 
4400 pulses). After the laser catheter had crossed the lesion, 
the vessel was subsequently pre-dilated and reconstructed 
with overlapping DES (Fig. 5). 
d) Combined ELCA and HSRA 
 This technique describes the use of ELCA followed by 
HSRA to facilitate delivery of secondary equipment where 
other adjunctive measures have failed. 
 Case example: A 68 year old male with refractory angina 
presented with a known RCA CTO. Cardiac MRI demon-
strated ischaemia in the RCA territory. The chosen interven-
tional strategy was an antegrade approach. A Pilot 200 wire 
was successfully advanced into the distal RCA beyond the 
CTO with assistance of a CrossBossTM CTO catheter. De-
spite pre-dilation with a 1.2mm balloon, further progress of 
larger calibre balloons and a Tornus were unsuccessful. Sub-
sequently, a 0.9mm, X-80 ELCA catheter was used to de-
 Fig. (5). Panel A: There is a proximal CTO of the left circumflex artery with a visible stump and an unambiguous proximal cap (arrow). 
Panel B: The proximal lesion cap is crossed with a Whisper MS guidewire that is advanced to the distal vessel. Panel C: The lesion could not 
be crossed despite use of multiple balloons, anchor balloons and a range of micro-catheters. Therefore, excimer laser coronary atherectomy 
(ELCA) is performed. Panel D: The vessel is reconstructed with overlapping DES.  
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liver 5000 pulses at a fluence of 80mJ/mm2 (repetition rate: 
80 Hz). This allowed passage of secondary equipment, al-
though the lesion remained undilatable. Therefore, a 1.75mm 
HSRA burr was then used to facilitate balloon dilation of the 
proximal lesion. The entire vessel was the reconstructed with 
overlapping DES back to the ostium (Fig. 6). 
e) HSRA to Modify a Stented But Resistant Lesion 
 A 57 year old ex-smoker with a remote previous PCI to 
the proximal RCA represented with a proximal CTO of the 
RCA. There was some proximal cap ambiguity, the distal 
cap was unambiguous, the occlusion was >20 mm and the 
septal collaterals were useable. The chosen strategy was a 
primary retrograde approach. A retrograde wire was success-
fully progressed via the LAD to the distal RCA true lumen. 
However, a Corsair could not be advanced to the posterior 
descending artery (PDA) due to extreme septal collateral 
tortuosity. This necessitated a switch to an antegrade wire 
strategy. After wiring the distal vessel true lumen, pre-
dilation was performed. The proximal RCA was heavily cal-
cified proximal to the original stent. A 2.5/10 cutting balloon 
(Boston Scientific, Natick, MA) was unsuccessfully used to 
modify this area. The vessel was re-constructed using Pro-
mus Element stents and post-dilated with 3.0 and 3.5 mm 
non-compliant balloons. An undilatable lesion just proximal 
to the original stent became apparent. However, this lesion 
had already been covered with a new DES that was now un-
der-expanded. A 1.5 burr was passed through this lesion into 
the proximal segment of the newly deployed stent. Further 
dilation with a 3.5 non-compliant balloon expanded this re-
 
 
Fig. (6). Panel A: There is a heavily calcified, resistant CTO in the proximal RCA. The lesion is crossed with a guidewire supported by a 
CrossBoss™ catheter, and the vessel is pre-dilated with a 1.2mm balloon. Progress of larger calibre balloons and a Tornus micro-catheter is 
unsuccessful due to the nature of the lesion (arrow). Panel B: At this stage, a 0.9mm X-80 ELCA catheter is used to modify this resistant 
lesion. Panel C: Following use of the ELCA, the vessel area is dilated again. However, the lesion remains resistant causing distortion of the 
balloon on inflation (arrow). Panel D: Due to the persistence of this lesion, a 1.75mm rotablation burr is used to modify the area. Panel E: 
The RCA is then reconstructed with overlapping DES back to the ostium. 
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sistant lesion. This area was covered by a short segment of 
overlapping DES and the proximal vessel was post-dilated 
with a 5.0 non-compliant balloon back to the RCA ostium 
(Fig. 7). The use of focused HSRA was unlikely to have 
caused significant stent disruption as the primary intention 
from the outset of the procedure was to cover the most 
proximal area with further stent deployment. 
f) HSRA Through a Heavily Calcified Sub-intimal Chan-
nel After Reverse CART 
 A 61 year old hypertensive, ex-smoker presented with 
exertional angina due to a calcified, tortuous CTO of the 
distal RCA. The proximal and distal caps were unambigu-
ous, the occlusion was long and useable septal collaterals 
were present. Further to an unsuccessful antegrade wire ap-
proach, a retrograde approach was adopted. After delivering 
a Corsair to the distal vessel retrogradely, a Confianza Pro 
wire (Asahi Intecc, Japan) was used to penetrate the distal 
CTO cap. This was exchanged for a knuckled Pilot 200 wire 
which was advanced retrogradely to the mid RCA in the sub-
intimal space. The “knuckle wire” technique is optimum for 
long segments of occlusion. The retrograde wire is manipu-
lated to create a loop at the tip, which is advanced through 
the CTO segment (usually in the subintimal space). This 
manoeuvre can be performed safely without perforation of 
the vessel [3]. After completing a reverse CART, an RG3 
guidewire was externalised. Further antegrade pre-dilation 
with 2.5, 3.0, 3.5 and 4.0 Apex balloons confirmed the per-
sistence of a focal, highly resistant lesion. A large dissection 
plane was evident at the site of the reverse CART. This le-
sion required modification with a 1.25 burr that was safely 
passed through the sub-intimal space and the dissected distal 
RCA. The vessel was then reconstructed with DES and post-
dilated to 4.0 mm. A follow-up angiogram after 4-months 
demonstrated widely patent stents (Fig. 8). 
g) HSRA at a Dissected Graft Insertion Point 
 A 79 year old female with previous CABG had intracta-
ble angina due to an occluded LAD and further occlusive 
disease at the insertion point of the left internal mammary 
artery (LIMA) graft which was non-functional. There was 
ambiguity of the proximal cap, the distal cap was unambigu-
 Fig. (7). Panel A: There is a heavily calcified CTO of the RCA proximal to a previously deployed stent. A retrograde guidewire and Corsair 
could not be advanced due to extreme vessel tortuosity. Panel B: The lesion is crossed with an antegrade wire and pre-dilated. The vessel is 
reconstructed with overlapping Promus Element DES (2.5/38 and 3/38). A heavily calcified lesion persists at the proximal entry point to the 
previous RCA stent with obvious balloon distortion (arrow). Panel C: This undilatable area is modified with a 1.5 rotablation through the 
proximal portion of the newly deployed stent. Panel D: A further, short stent is deployed to overlap with the initial stents, and post-dilated 
with a 5.0 non-compliant balloon. 
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ous, the occlusion was long, and filled from epicardial col-
laterals off the PDA (via a patent SVG). A combined ante-
grade and retrograde approach was undertaken with the dis-
tal LAD true lumen accessed retrogradely via a Sion wire 
and a Corsair. After wire exchange, a knuckled Fielder XT 
(Asahi Intecc, Japan) was then passed through the CTO 
segment to the proximal cap of the occlusion. An antegrade 
knuckled Fielder XT was then overlapped with the retro-
grade wire within the CTO segment. A reverse CART was 
performed and an RG3 guidewire was externalised. The 
LAD was then pre-dilated with 1.5, 2.0 and 2.5 mm bal-
loons. However, a focal area of resistant disease was appar-
ent in the distal LAD at the LIMA insertion and this per-
sisted despite high pressure balloon inflations and balloon 
rupture. The LAD was reconstructed with overlapping Pro-
mus Element DES from the distal LAD back to the left 
mainstem (LMS) ostium. The stented area was post-dilated 
to 2.5 mm, 3 mm, 3.5 mm and 4 mm, from the distal LAD to 
LMS. However, despite very high pressure post-dilation at 
the LIMA anastomosis, the calcific area persisted. This was 
modified with a 1.25 burr that was easily advanced through 
the long segment of stented LMS and LAD. The remaining 
vessel was reconstructed with a 2.25 mm DES and post-
dilated to 2.5 mm. Follow-up repeat angiography at 6-
months showed widely patent stents (Fig. 9). 
 Historical practice has been to avoid using HSRA in the 
presence of intimal disruption and dissection. The current 
Rotablator® Rotational Atherectomy System (Boston Scien-
 
 
Fig. (8). Panel A: There is a heavily calcified CTO of the RCA (arrow) that is supplied by collaterals from calcific LAD septal branches. 
Panel B: A reverse CART procedure has performed. After externalising a guidewire, antegrade balloon dilations with 2.5, 3.0, 3.5, and 4.0 
balloons are performed but a resistant, focal lesion persists (arrow). Panel C: This resistant lesion is modified with a 1.25 burr (arrow). A 
large dissection plane is also evident in the distal segment of the RCA. Rotablation is safely performed through the surrounding dissection 
plane. Panel D: The vessel is reconstructed with overlapping DES. Panel E: Follow-up angiogram at 4-months demonstrating widely patent 
stents. 
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tific, Natick, MA) operating instructions cite use of the de-
vice in the presence of SVGs and angiographic evidence of 
dissection as contra-indicated. We have demonstrated suc-
cessful use of HSRA through calcific diseased segments in 
the sub-intimal space. Rotablation preferentially modifies 
calcific segments with relative sparing of elastic sub-intimal 
and adventitial tissue. Use of complimentary ELCA in the 
setting of HSRA has also been demonstrated to be feasible 
and safe under appropriate circumstances. 
DISCUSSION 
 An increasing burden of resistant, calcific coronary le-
sions can be anticipated by the interventional cardiologist in 
future clinical practice. This reflects changing patient demo-
graphics with an elderly population and higher rates of 
chronic kidney disease, diabetes mellitus, and coronary graft 
failure. Thus, challenges with the successful revascularisa-
tion of such chronic occlusions can be anticipated. Standard 
 
 
Fig. (9). Panel A: There is a CTO of the native LAD with significant occlusive disease at the LIMA insertion point. Panel B: A retrograde 
Sion wire is advanced into the distal LAD lumen aided by a Corsair micro-catheter. A reverse CART procedure is performed after an ante-
grade knuckled Fielder XT wire was advanced to overlap with the retrograde wire. The LAD is then dilated and reconstructed with overlap-
ping Promus Element DES back to the LMS. After stent deployment and high-pressure balloon inflation, a focal, resistant lesion is seen in 
the distal LAD at the LIMA insertion point (arrow). Panel C: This resistant lesion is modified with a 1.25mm burr (arrow), which is ad-
vanced through the long segment of stented LMS and LAD. Panel D: The final result following further stent deployment, post dilation and 
balloon angioplasty of the terminal vessel with a 1.5mm balloon. Panel E: Follow-up angiogram after 6-months. 
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techniques deployed to negotiate coronary lesions are un-
likely to be successful alone. Thus, the operator should be 
prepared to acquire skills and gain understanding of a range 
of adjunctive techniques to facilitate successful CTO revas-
cularisation. In the era of contemporary CTO PCI, high suc-
cess rates can be anticipated in the hands of appropriately 
trained and experienced operators. Increased operator expe-
rience will enhance successful angiographic and clinical out-
comes. The outcome of CTO revascularisation is dependent 
on clinical experience and, with a correlation between opera-
tor experience in general and CTO experience cases in par-
ticular [4]. This was reported in a study comparing technical 
success rates in 636 cases performed by retrograde operators 
(RO) and non–retrograde operators (NRO) of 58.95 vs. 
75.2% for NRO vs. RO (p<0.0001). There were no differ-
ences in adverse outcomes between the two operator groups. 
Of note, the technical success rate of the RO group increased 
with time (up to 90%); whereas no change was seem in the 
NRO group, demonstrating that high CTO-specific operator 
case volume correlated with improved technical success rates.  
 The challenges associated with CTO revascularisation 
can be broadly categorised into those related to lesion cross-
ing, and those related to lesion modification. Novel tech-
nologies, wire strategies and device developments have 
complimented standard approaches to increase the success 
rates of CTO recanalisation.  
 This article has reviewed and discussed the range of ap-
proaches that can be considered when faced with the chal-
lenge of resistant, calcific lesions. The cases demonstrate the 
successful implementation of these strategies in the recanali-
sation of heavily calcified CTOs. In addition, the authors 
have demonstrated the successful deployment of much more 
‘extreme’ techniques to facilitate CTO revascularisation, 
where all other methods have failed. Such techniques should 
be considered only when other strategies have failed. In the 
cases described, several of the devices were used in a non-
IFU setting, and thus, cannot be recommended as routine 
practice.  
 In summary, in the contemporary era of CTO PCI, there 
is theoretically no exclusion to successful revascularisation. 
With an increasing burden of complex, calcific CTOs, a 
range of adjunctive strategies to facilitate successful reca-
nalisation may need to be considered. Successful revascu-
larisation correlates strongly with operator experience. The 
ranges of techniques described above are teachable and repro-
ducible with increased operator experience and confidence. 
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